Last update 11 Jul 2024
Excelmab, Inc.

Excelmab, Inc.

Private Company|
2016|
Guangdong Sheng, China
|
10-50
|

Overview

Basic Info

Introduction
ExcelMab is a biopharmaceutical developer of bispecial antibodies, focusing on the research and development of tumor immunity bispecial antibodies. Through the bispecial antibody platform independently developed and built, ASMED uses antibody genetic engineering construction technology to develop therapeutic bispecial antibody drugs for tumor diseases, providing new solutions for the field of tumor therapy. A number of dual antibody products have been developed to cover breast cancer, gastric cancer, chronic lymphocytic leukemia and other indications.

Tags

Neoplasms
Digestive System Disorders
Immune System Diseases
Bispecific T-cell Engager (BiTE)

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 Jul 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
4
Preclinical
IND Approval
1
1
Phase 1 Clinical
Phase 2 Clinical
1
6
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free